Leksell Vantage Stereotactic System - India CDSCO Medical Device Registration
Leksell Vantage Stereotactic System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000568_7ac1a3dba98d295e2405ae63d7aad815_547779c7d29239241a2916800c63fb1b. This device is marketed under the brand name Leksell Vantage Stereotactic System. The license holder is ELEKTA MEDICAL SYSTEMS INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
Leksell Vantage Stereotactic System
License Holder
ELEKTA MEDICAL SYSTEMS INDIA PRIVATE LIMITEDDevice Class
Approving Authority
CDSCO
Product Information
The Intended Purpose of Leksell Vantage Stereotactic System is target localization and fixation of the patient head in a coordinate system in order to perform stereotactic neurosurgical procedures, for example; deep brain stimulation, lesioning, biopsies, targeted injections, aspirations and minimal invasive tumor treatments. In addition, the Leksell® Vantage™ Head Frame System is intended to be used for target localization and head fixation during intracranial stereotactic radiosurgery with the Leksell Gamma Knife
